J&J | Le Coût Des Ventes



Cost Of Sales Changement Date
AbbVie USD 4.35B 344M 2025-06
Abbott USD 5.27B 834M 2025-06
Amgen USD 3.01B 406M 2025-06
AstraZeneca USD 2.47B 232M 2025-06
Baxter International USD 1.82B 55M 2025-06
Bayer EUR 4.36B 1.26B 2025-06
Becton, Dickinson and Co. USD 2.88B 140M 2025-06
Biogen USD 605M 24.3M 2025-06
Boston Scientific USD 1.88B 409M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
CONMED USD 154.02M 13.93M 2025-06
Cooper Companies USD 368.3M 45.1M 2025-07
Dexcom USD 468.3M 21.3M 2025-06
Edwards Lifesciences USD 344.4M 42.8M 2025-06
Eli Lilly USD 2.45B 223.6M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
GlaxoSmithKline GBP 2.16B 241M 2025-06
Globus Medical USD 278.95M 83.56M 2025-06
Hologic USD 447.2M 2.6M 2025-06
Insulet USD 196.9M 36.9M 2025-06
Integra LifeSciences USD 206.27M 38.76M 2025-06
Intuitive Surgical USD 822.1M 26.4M 2025-06
J&J USD 7.6B 304M 2025-06
Medtronic USD 3.46B 346M 2025-07
Merck USD 2.82B 53M 2025-06
Merit Medical Systems USD 197.98M 535.35M 2025-06
Novartis USD 3.32B 95M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.99B 103M 2025-06
Stryker USD 2.18B 59M 2025-06
Tandem Diabetes Care USD 114.82M 1.19M 2025-06
Teva Pharmaceutical Industries USD 2.07B 97M 2025-06
Vertex Pharmaceuticals USD 407.5M 44.5M 2025-06
Zimmer Biomet Holdings USD 752.8M 203M 2025-06
Zoetis USD 682M 60M 2025-06


J&J Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.